Telford, PA, United States of America

Terrence M Ciccarone


Average Co-Inventor Count = 4.2

ph-index = 11

Forward Citations = 515(Granted Patents)


Location History:

  • Harleysville, PA (US) (1992)
  • East Greenville, PA (US) (1996)
  • Telford, PA (US) (1996 - 2002)

Company Filing History:


Years Active: 1992-2002

Loading Chart...
15 patents (USPTO):

Title: The Innovative Contributions of Terrence M Ciccarone

Introduction

Terrence M Ciccarone is a notable inventor based in Telford, PA (US). He has made significant contributions to the field of biochemistry, particularly in the development of compounds that target oncogenic processes. With a total of 15 patents to his name, Ciccarone's work has the potential to impact cancer treatment significantly.

Latest Patents

Ciccarone's latest patents focus on inhibitors of prenyl-protein transferase. The first patent describes peptidomimetic macrocyclic compounds that inhibit prenyl-protein transferase and the prenylation of the oncogene protein Ras. This invention is directed towards creating chemotherapeutic compositions that utilize these compounds to inhibit the oncogenic processes associated with Ras. The second patent also targets prenyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras, further emphasizing the importance of his research in developing effective cancer therapies.

Career Highlights

Terrence M Ciccarone is currently associated with Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in cancer treatment.

Collaborations

Some of Ciccarone's notable coworkers include S Jane deSolms and Theresa M Williams. Their collaborative efforts have likely enhanced the research and development of innovative therapeutic solutions.

Conclusion

Terrence M Ciccarone's contributions to the field of biochemistry and oncology through his patents and work at Merck & Company, Inc. highlight his role as a significant inventor. His innovative approaches to inhibiting oncogenic processes are paving the way for future advancements in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…